Spike-and-wave complexes and seizure exacerbation caused by carbamazepine

European Journal of Neurology

Volumn 9, Issue 1, 2002, Pages 41-47

  Kochen, S ^a,b   Giagante, B ^a   Oddo, S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Epilepsy Center   (Argentina)

Author keywords

Antiepileptic drugs; Carbamazepine; Carbamazepine adverse effects; Spike wave discharges

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; DISEASE EXACERBATION; DRUG WITHDRAWAL; ELECTRICITY; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC DISCHARGE; FEMALE; FOLLOW UP; FRONTAL LOBE EPILEPSY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ROLANDIC EPILEPSY; SCHOOL CHILD; SEIZURE; SPIKE WAVE;

ADOLESCENT; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEIZURES; TREATMENT OUTCOME;

EID: 0036388405     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2002.00317.x     Document Type: Article

References (41)

1. Avanzini G, Vergnes M, Spreafico R, Marescaux C (1993). Calcium-dependent regulation of genetically determined spike and waves by the reticular thalamic nucleus of rats. Epilepsia 34:1-7.
2. Bauer J (1996). Seizure inducing effects of antiepileptic drugs: a review. Acta Neurl Cand 94:367-377.
3. Bensten KD, Gram L, Veje A (1983). Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. A controlled study. Acta Neurol Scand 67:235-241.
4. Blume WT, Pillay N (1985). Electrographic and clinical correlates of secondary bilateral synchrony. Epilepsia 26:636-641.
5. Callaham DJ, Noetzel MJ (1992). Prolonged absence status epilepticus associated with carbamazepine therapy increased intracranial pressure, and transient MRI abnormalities. Neurology 42:2198-2201.
6. Caraballo R, Fontana E, Michelizza B et al. (1989). Carbamazepine, ··assenze atipiche··, ··crisi atoniche·· e stato di PO continua del sonno (POCS). Boll Lega It Epil 66/67: 379-381.
7. Carter-Snead OC, Hosey LC (1985). Exacerbation of seizures in children by carbamazepine. N Engl J Med 313:916-921.
8. Cereghino JJ, Brock JC, Van Meter JC, Penry JK, Smith LD, White BG (1974). Carbamazepine for epilepsy. Neurology 24:401-410.
9. Collaborative Group for Epidemiology of Epilepsy (1988). Adverse reaction to antiepileptic drugs: a follow-up study of 355 patients with chronic antiepileptic drug treatment. Epilepsia 29:787-793.
10. Dhuna A, Pascual-Leone A, Talwar D (1991). Exacerbation of partial seizures and onset of non-epileptic myoclonus with carbamazepine. Epilepsia 32:275-278.
11. Gibbs FA, Gibbs EL (1964). Atlas of Electroencephalography, Vol. 3. Adison-Wesley, Reading, MA.
12. Gram L (1991). How do you treat epilepsy. In: Dam M, ed. A Practical Approach to Epilepsy. Pergamon Press, New York, pp. 105-135.
13. Gram L, Jensen PK (1989). Carbamazepine toxicity. Antiepileptic Drugs, 3rd edn. Raven Press, New York, pp. 555-565.
14. Hart RG, Easton JD (1981). Carbamazepine and hematological monitoring. Ann Neurol 11:309-312.
15. Holmes GL (1995). Carbamazepine toxicity. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th edn. Raven Press, New York, pp. 567-579.
16. Horn CS, Ater SB, Hurst DL (1986). Carbamazepine - exacerbated epilepsy in children and adolescents. Pediatr Neurol 2:340-345.
17. Hosford DA, Clark S, Cao Z et al. (1992). The role of GABA B receptor activation in absence seizures of lethargic mice. Science 257:398-401.
18. Jasper H (1958) Report of committee of methods of clinical exam in EEG. Electroencephalogr Clin Neurophysiol 10:370-375.
19. Johnsen SD, Tarby TJ, Sidell AD (1984). Carbamazepine-induced seizures. Ann Neurol 16:392-393.
20. Kalff R, Houtkooper MA, Meyer JW et al. (1984). Carbamazepine and serum sodium levels. Epilepsia 25:390-397.
21. Karenen T, Silvenius Y (1983). Side effects of carbamazepine, valproate and clonazepam during long term treatment of epilepsy. Acta Neurol Scand 97 (Suppl.):69-80.
22. Lerman P (1986). Seizures induced or aggravated by anticonvulsants. Epilepsia 27:706-710.
23. Liporace J, Sperling M, Dichter M (1994). Absence seizures and carbamazepine in adults. Epilepsia 35:1026-1028.
24. Liu Z, Vergnes M, Depaulis A, Marescaux C (1992). Involvement of intrathalamic GABA-B neurotransmission in the control of absence seizures in the rats. Neuroscience 1:87-93.
25. Marescaux C, Vergnes M, Depaulis A (1992). Neurotransmission in rats' spontaneous generalized nonconvulsive epilepsy. Epilepsy Res 8 (Suppl.):355-343.
26. Mattson RH (1995). Selection of antiepileptic drug therapy. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th edn. Raven Press, New York, pp. 137-148.
27. Neufeld MY (1993). Exacerbation of focal seizures due to carbamazepine treatment in an adult patient. Clin NeuroPharmacol 16:359-361.
28. Olsen R, Avoli M (1997). GABA and epileptogenesis. Epilepsia 38:399-407.
29. Pazzaglia P, D'Allesandro R, Ambrossetto G, Lugaresi E (1985). Drop attacks an omnious change in the evolution of partial epilepsy. Neurology 35:1725-1730.
30. Perucca E, Gram L, Avanzini G, Dulac O (1998). Antiepileptic drugs as a cause of worsening of seizures. Epilepsia 39:5-17.
31. Pryse-Phillips WEM, Jeavons PM (1970). Effect of carbamazepine (tegretol) on the electroencephalogrph and ward behavior of patients with chronic epilepsy. Epilepsia 11:263-273.
32. Rodin EA, Rim CS, Rennick PM (1974). The effects of carbamazepine in patients with psychomotor epilepsy: results of double-blind study. Epilepsia 15:547-561.
33. Scheffner D, Schiefer J (1972). The treatment of epileptic children with carbamazepine. Epilepsia 13:819-828.
34. Schoeman JF, Elyas AA, Brett EM, Lascelles PT (1984). Correlation between plasma carbamazepine 10,11 epoxide concentration and drug side effects in children with epilepsy. Dev Med Child Neurol 24:756-764.
35. Shields WD, Saslow E (1983). Myoclonic, atonic and absence seizures following institution of carbamazepine therapy in children. Neurology 33:1487-1489.
36. Silverstein FS, Parrish MA, Johnston MV (1982). Adverse reactions to carbamazepine in children with epilepsy. Ann Neurol 12:198-199.
37. So EL, Ruggles KH, Cascino GD, Ahmann PA, Eatherford KW (1994). Seizure exacerbation and status epilepticus related to carbamazepine-10, 11 epoxide. Ann Neurol 35:743-746.
38. Talwar D, Arora MS, Sher PK (1994a). EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 35:1154-1159.
39. Talwar D, Maninder S, Phyllis K (1994b). EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 35:1154-1159.
40. Wallace S (1978). Carbamazepine in childhood seizures. Dev Med Child Neurol 20:223-226.
41. Wilder BJ, Rangel R (1987). Carbamazepine efficacy in adults with partial and generalized tonic-clonic seizures. Epilepsia 28:S25-S28.